UMass med­ical school’s man­u­fac­tur­ing busi­ness trims 36 po­si­tions

Mass­Bi­o­log­ics has no­ti­fied 36 em­ploy­ees that their roles will be cut ef­fec­tive Feb. 3 to “right-size” its op­er­a­tions, a spokesper­son con­firmed to End­points News, adding that there will be around 80 em­ploy­ees left af­ter the lay­offs.

“Mass­Bi­o­log­ics is not im­mune from mar­ket-re­lat­ed fac­tors im­pact­ing so many biotech and life sci­ences com­pa­nies at this time,” the spokesper­son not­ed, adding that such chal­lenges in­clude “high over­head, un­der­uti­lized bio­man­u­fac­tur­ing ca­pac­i­ty and, in this case, steadi­ly wan­ing de­mand for Td [tetanus and diph­the­ria tox­oids ad­sorbed] vac­cine.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER